In trading on Wednesday, shares of Sana Biotechnology Inc (Symbol: SANA) entered into oversold territory, hitting an RSI reading of 28.0, after changing hands as low as $13.05 per share.

The Seattle, WA-based company was founded in 2018 and plans to list on the Nasdaq under the symbol SANA. Sana Biotechnology filed confidentially on November 10, 2020.

SEATTLE, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA), a company focused on creating and delivering engineered cells as medicines, today announced the closing of its ...